Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Return on Equity: 2011-2016

Historic Return on Equity for Tenax Therapeutics (TENX) over the last 1 years, with Dec 2016 value amounting to -1.77%.

  • Tenax Therapeutics' Return on Equity was N/A to -1.77% in Q4 2016 from the same period last year, while for Dec 2016 it was -1.77%, marking a year-over-year change of. This contributed to the annual value of -1.02% for FY2016, which is N/A change from last year.
  • According to the latest figures from Q4 2016, Tenax Therapeutics' Return on Equity is -1.77%, which was up 38.37% from -2.88% recorded in Q3 2016.
  • Tenax Therapeutics' 5-year Return on Equity high stood at 74.34% for Q2 2013, and its period low was -2.88% during Q3 2016.
  • Its 1-year average for Return on Equity is -2.32%, with a median of -2.32% in 2016.
  • Data for Tenax Therapeutics' Return on Equity shows a peak YoY soared of 4,866bps (in 2013) over the last 5 years.
  • Over the past 3 years, Tenax Therapeutics' Return on Equity (Quarterly) stood at 43.07% in 2012, then spiked by 4,866bps to 74.34% in 2013, then reached -1.77% in 2016.
  • Its Return on Equity stands at -1.77% for Q4 2016, versus -2.88% for Q3 2016 and 74.34% for Q2 2013.